If you purchased GSK ADRs during the Class Period you may be entitled to compensation without payment of any out of pocket ...
The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...
Fortune curated a list of female leaders at the helm of European companies across the continent’s biggest industries.
In a cohort of more than 11,000 patients from the U.K. and Ireland, a comparable proportion of new adalimumab users achieved ...
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it ...
LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results